In the BioHarmony Drug Report Database
Amoxicillin
Amoxil, Larotid, Moxatag (amoxicillin) is a small molecule pharmaceutical. Amoxicillin was first approved as Amoxil on 1982-01-01. It is used to treat actinomycosis, bacterial infections, bacterial skin diseases, chlamydia infections, and duodenal ulcer amongst others in the USA. Amoxicillin’s patents are valid until 2027-05-07 (FDA).
Trade Name
|
Amoxil, Larotid, Moxatag |
|---|---|
Common Name
|
amoxicillin |
ChEMBL ID
|
CHEMBL1082 |
Indication
|
actinomycosis, bacterial infections, bacterial skin diseases, chlamydia infections, duodenal ulcer, helicobacter infections, human bites, listeriosis, lyme disease, otitis media, sinusitis, soft tissue infections, streptococcal infections, urinary tract infections |
Drug Class
|
Penicillins |
Image (chem structure or protein)